Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice

Sirolimus (SRL) is widely used as an immunosuppressant to prevent graft rejection, despite the risk of impairing glucose metabolism. Metformin (MET) can reduce the detrimental effects of SRL in many patients, including diabetes and renal transplant recipients. Limited in vivo studies have reported o...

Descripción completa

Detalles Bibliográficos
Autores principales: Albawardi, Alia, Saraswathiamma, Dhanya, Sharma, Charu, Elomami, Abdulghani, Souid, Abdul-Kader, Almarzooqi, Saeeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866855/
https://www.ncbi.nlm.nih.gov/pubmed/36674739
http://dx.doi.org/10.3390/ijms24021223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866855/
https://www.ncbi.nlm.nih.gov/pubmed/36674739
http://dx.doi.org/10.3390/ijms24021223

Ejemplares similares